MedTrace Logo

Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

NCT01198171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 243

Last updated 2024-08-14

No results posted yet for this study

Summary

This research study is studying racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. DNA analysis of tumor tissue may also help doctors predict how well patients will respond to treatment.

Conditions

  • Stage I Uterine Corpus Cancer
  • Stage II Uterine Corpus Cancer
  • Stage III Uterine Corpus Cancer
  • Stage IV Uterine Corpus Cancer

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Study of Socioeconomic and Demographic Variables

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Rodney Rocconi · Gynecologic Oncology Group

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198171 on ClinicalTrials.gov